Ex-NHSI directors receive payouts of up to £300k
Four directors who left NHS Improvement amid its effective merger with NHS England received exit packages worth between £150,000 to £300,000. (Source: HSJ)
Source: HSJ - July 16, 2019 Category: UK Health Source Type: news

Boehringer buys cancer vaccines biotech
Boehringer Ingelheim announced its acquisition of AMAL Therapeutics, a private Swiss biotechnology company focused on cancer immunotherapy. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 15, 2019 Category: Pharmaceuticals Source Type: news

AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
NORTH CHICAGO, Ill., July 15, 2019 -- (Healthcare Sales & Marketing Network) -- AbbVie (NYSE: ABBV) announced today that it has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel approaches to target the STING (... Biopharmaceuticals, Mergers & Acquisitions AbbVie, Mavupharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2019 Category: Pharmaceuticals Source Type: news

Flex Pharma shareholders OK reverse-merger after drug failure
Shareholders have approved a plan making Flex Pharma, the neurobiology-focused biotech started five years ago by a Nobel Prize winner and one of the founders of Alnylam Pharmaceuticals Inc., into a shell company for a privately held Houston cancer drug developer.   Flex Pharma (Nasdaq: FLKS) was co-founded in 2014 by Nobel Prize Winner Rod MacKinnon and serial entrepreneur Christoph Westphal. The company began looking for a merger partner after its “tolerability concerns” arose during a mid-stage… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 15, 2019 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Boehringer Ingelheim acquires AMAL Therapeutics, significantly enriching its cancer immunology portfolio with novel cancer vaccines platform
Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing first-in-class therapeutic cancer vaccines derived from its technology platform KISIMA. AMAL's lead vaccine ATP128 is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month. (Source: World Pharma News)
Source: World Pharma News - July 15, 2019 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news

NIH and partners to launch HIV vaccine efficacy trial in the Americas and Europe
(NIH/National Institute of Allergy and Infectious Diseases) The National Institutes of Health and partners today announced plans to conduct a Phase 3 HIV vaccine efficacy trial at multiple clinical research sites in North America, South America and Europe. The trial, called HPX3002/HVTN 706 or Mosaico, will assess whether an investigational vaccine regimen designed to induce immune responses against a variety of global HIV strains can safely and effectively prevent HIV acquisition among men who have sex with men and transgender people. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 15, 2019 Category: Infectious Diseases Source Type: news

Amazon Primed:'Vesta' Project Ramped Up, NHS and Alexa Deal,'Just Eats' Next Target For Acquisition?
Amazon Primed is the short version of'What Did Amazon Do This Week'- a subscription newsletter service that covers everything Amazon does every week. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 14, 2019 Category: Pharmaceuticals Authors: Paul Armstrong, Contributor Source Type: news

Not just a vaccine company: How this Gaithersburg biotech CEO plans to grow the business
The Gaitherburg biotech ’s CEO, not yet a year into his tenure, sees the prospect of more acquisitions or licensing deals going forward. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 12, 2019 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news

Not just a vaccine company: How this Gaithersburg biotech CEO plans to grow the business
The Gaitherburg biotech ’s CEO, not yet a year into his tenure, sees the prospect of more acquisitions or licensing deals going forward. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 12, 2019 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Florida company buys Pennsylvania medical marijuana dispensary operations, has eyes on Pittsburgh
Jushi Holdings, a Florida-based cannabis and hemp company, closed its previously announced $63 million acquisition of all of the membership interests in Franklin Bioscience-Penn LLC. The deal covers the Pennsylvania medical marijuana dispensary operation of Franklin Bioscience and its subsidiaries, which have a total of four dispensary permits issued by the state health department. Those permits allow for the holder to open a total of 12 medical marijuana dispensaries in Penns ylvania. On the east… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 12, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Florida company buys Pennsylvania medical marijuana dispensary operations, has eyes on Pittsburgh
Jushi Holdings, a Florida-based cannabis and hemp company, closed its previously announced $63 million acquisition of all of the membership interests in Franklin Bioscience-Penn LLC. The deal covers the Pennsylvania medical marijuana dispensary operation of Franklin Bioscience and its subsidiaries, which have a total of four dispensary permits issued by the state health department. Those permits allow for the holder to open a total of 12 medical marijuana dispensaries in Penns ylvania. On the east… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 12, 2019 Category: Biotechnology Authors: John George Source Type: news

Jushi completes $63M deal for Franklin Biosciences's Pa. medical marijuana dispensary operations
Jushi Holdings, a Florida-based cannabis and hemp company, closed its previously announced $63 million acquisition of all of the membership interests in Franklin Bioscience-Penn LLC. The deal covers the Pennsylvania medical marijuana dispensary operation of Franklin Bioscience and its subsidiaries, which have a total of four dispensary permits issued by the state health department. Those permits allow for the holder to open a total of 12 medical marijuana dispensaries in Penns ylvania. In this region,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 12, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Jushi completes $63M deal for Franklin Biosciences's Pa. medical marijuana dispensary operations
Jushi Holdings, a Florida-based cannabis and hemp company, closed its previously announced $63 million acquisition of all of the membership interests in Franklin Bioscience-Penn LLC. The deal covers the Pennsylvania medical marijuana dispensary operation of Franklin Bioscience and its subsidiaries, which have a total of four dispensary permits issued by the state health department. Those permits allow for the holder to open a total of 12 medical marijuana dispensaries in Penns ylvania. In this region,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 12, 2019 Category: Biotechnology Authors: John George Source Type: news

Varian to highlight RT management system at AAPM meeting
Radiation therapy (RT) firm Varian Medical Systems plans to highlight its automated...Read more on AuntMinnie.comRelated Reading: Varian to buy 2 Boston Scientific product lines Varian secures Tenn. Noona software contract Varian closes acquisition of cancer treatment provider Varian adds 2 interventional companies to roster Varian to acquire cancer treatment provider (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 12, 2019 Category: Radiology Source Type: news

Varian to highlight RT management system at AAPM
Radiation therapy (RT) firm Varian Medical Systems plans to highlight its automated...Read more on AuntMinnie.comRelated Reading: Varian to buy 2 Boston Scientific product lines Varian secures Tenn. Noona software contract Varian closes acquisition of cancer treatment provider Varian adds 2 interventional companies to roster Varian to acquire cancer treatment provider (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 11, 2019 Category: Radiology Source Type: news

TransEnterix Wins Back Investors with Asset Sale
TransEnterix investors got a little spooked in the first half of 2019, but the company's recent asset sale was rewarded with a stock spike nearly 26% on Wednesday.  5 Quick Bits About TransEnterix Stock Movement on Wednesday (July 10, 2019) Stock symbol: TRXC on the New York Stock Exchange Day's price range: $1.27 to $1.94 52-week stock price range: $1.03 to $6.98 Wednesday's trading volume: 14.03 million shares Average trading volume: $2.55 million shares TransEnterix    RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE Americ...
Source: MDDI - July 11, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

NHS England hired consultancy to find out what it is responsible for
NHS England paid external consultants more than £200,000 to ‘map’ its responsibilities ahead of the merger with NHS Improvement, HSJ has learned. (Source: HSJ)
Source: HSJ - July 11, 2019 Category: UK Health Source Type: news

Hillrom Announces Sale Of Surgical Consumable Products
Transaction underscores Hillrom's category leadership strategy and vision to accelerate growth by Advancing Connected Care CHICAGO, July 10, 2019 -- (Healthcare Sales & Marketing Network) -- Hill-Rom Holdings, Inc. (NYSE: HRC), which recently rebranded... Devices, Surgery, Acquisitions Hill-Rom, Hillrom, Advancing Connected Care (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 10, 2019 Category: Pharmaceuticals Source Type: news

How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs
After its acquisition of Warp Drive Bio last year, this Redwood City biotech company took its cancer-fighting trek into the "undruggable" universe. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 9, 2019 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs
After its acquisition of Warp Drive Bio last year, this Redwood City biotech company took its cancer-fighting trek into the "undruggable" universe. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 9, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Zetta Medical Technologies accepts acquisition
Zetta Medical Technologies has a new owner. Agiliti has acquired the medical...Read more on AuntMinnie.comRelated Reading: FDA clears Zetta's Zoom MRI software FDA clears Zetta's CT dose management software Zetta nets FDA OK for CT dose software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 9, 2019 Category: Radiology Source Type: news

Cutera snags Vyaire Medical ’ s Mowry for CEO | Personnel Moves, July 9, 2019
Cutera (NSDQ:CUTR) said today that it snagged Vyaire Medical CEO David Mowry to be its new CEO, effective immediately. The aesthetic device maker in January fired president & CEO James Reinstein after the company missed expectations for its 2018 top line, naming COO Jason Richey as interim chief executive. Mowry led Tornier to a $3.3 billion merger with Wright Medical in October 2015. After leaving the COO role at Wright the next year, he was tapped to lead Vyaire Medical, a rollup of four respiratory businesses BD acquired in the March 2015 deal for CareFusion. Initially a joint venture partner in Vyaire with pri...
Source: Mass Device - July 9, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Business/Financial News Camstent Cerner Corp. Cutera Inc. Dentsply Sirona Inari Medical Medline Industries Inc. Neuronetics Ocular Therapeutix Personnel Moves Pfizer Pure Bioscience Source Type: news

How this Peninsula biotech plans to turn a $100 million round into 'next generation' of cancer drugs
After its acquisition of Warp Drive Bio last year, this Redwood City biotech company took its cancer-fighting trek into the "undruggable" universe. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 9, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

Spark, Roche extend deadline for completing $4.3 billion merger into early 2020
Roche and Philadelphia gene therapy pioneer Spark Therapeutics have amended their proposed $4.3 billion merger deal to extend the deadline for completing the transaction from the end of this year to the end of April 2020. In documents filed with the Securities and Exchange Commission, Spark said the companies agreed to the new date in order to provide them with additional time to satisfy the regulatory conditions, with respect to antitrust laws, "in the event that additional time is necessary." Roche,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 8, 2019 Category: Biotechnology Authors: John George Source Type: news

How Did Medtronic ’s HVAD Perform in LATERAL Trial?
Medtronic’s HeartWare HVAD pump system could get a significant boost after performing well in the LATERAL clinical trial. The Dublin-based company presented results from the study at the American Society for Artificial Internal Organs 65th Annual Conference, that showed patients who received the system had 95% freedom from disabling stroke at two years. The medtech giant now plans to launch a global registry to collect additional clinical evidence to further characterize survival, adverse events, and economic benefits of the HVAD System. The HVAD Pump is a left ventricle assist device (LVAD) approved in t...
Source: MDDI - July 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Montco home medical equipment supplier going public in merger deal
AdaptHealth, a Plymouth Meeting-based distributor of home medical equipment, is going public through a business combination deal that will create a combined company with a $800 million market capitalization. The deal will join AdaptHealth with DFB Healthcare Acquisitions Corp. (NASDAQ: DFBH). a special purpose acquisition company that is already publicly traded and sponsored by Deerfield Management Inc. of New York. Once the deal is completed, plans are for DFB to be renamed AdaptHealth Holding… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 8, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Agiliti snags Zetta Medical
Healthcare technology management firm Agiliti said it acquired Zetta Medical Technologies for an undisclosed amount. Lake Zurich, Ill.-based Zetta offers engineering services, parts and pre-owned medical imaging equipment via a network of OEM trained-engineers, according to Minneapolis-based Agiliti, formerly known as Universal Hospital Services. “Zetta’s specialized capabilities and technical expertise are an ideal complement to our expanding platform of clinical engineering services,” CEO Tom Leonard said in prepared remarks. “This acquisition builds upon our outsourced and supplemental biomedical...
Source: Mass Device - July 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Imaging Mergers & Acquisitions Wall Street Beat Agiliti Zetta Source Type: news

A View From Inside Cigna's $67 Billion Acquisition Of Express Scripts
Cigna recently closed one of the largest acquisitions when its deal with Express Scripts closed in late 2018. One of the executives tasked with overseeing the integration has been Express Scripts CTO Phil Finucane. He describes the steps his counterparts and he undertook to achieve success. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 8, 2019 Category: Pharmaceuticals Authors: Peter High, Contributor Source Type: news

Net Health to acquire Alpahretta-based Optima Healthcare
Net Health, a Pittsburgh-based company that offers cloud-based solutions for specialized outpatient care, is set to acquire Alpharetta-based Optima Healthcare Solutions for an undisclosed amount.   The acquisition of Optima, a cloud-based electronic medical record software company, is likely to close by next week, Josh Pickus, CEO of Optima said. The companies are working to complete integration into a single company by the end of the year.  The integration will allow Net Health to expan d its… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 5, 2019 Category: Pharmaceuticals Authors: Brendan Ward Source Type: news

Net Health to acquire Alpahretta-based Optima Healthcare
Net Health, a Pittsburgh-based company that offers cloud-based solutions for specialized outpatient care, is set to acquire Alpharetta-based Optima Healthcare Solutions for an undisclosed amount.   The acquisition of Optima, a cloud-based electronic medical record software company, is likely to close by next week, Josh Pickus, CEO of Optima said. The companies are working to complete integration into a single company by the end of the year.  The integration will allow Net Health to expan d its… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 5, 2019 Category: American Health Authors: Brendan Ward Source Type: news

Digirad board approves deal to acquire ATRM Holdings
Digirad Corp. (NSDQ:DRAD) said this week that its board of directors approved a deal to buy ATRM Holdings as a “kick-off” transaction to convert Digirad to a diversified holding company. As part of the acquisition, Digirad plans to create Series A non-convertible, cumulative, perpetual preferred stock with a stated value of $10 apiece. ATRM shareholders are slated to receive consideration consisting of 0.03 shares of Digirad Series A preferred stock for every ATRM common share. Also, each Series B preferred stock of ATRM will be exchanged for 2.5 shares of Digirad’s Series A preferred stock, accordin...
Source: Mass Device - July 5, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Mergers & Acquisitions Wall Street Beat Digirad Corp. Source Type: news

Everything is bigger in Texas — and now so is HCA
Sam Hazen said during the company ’s first-quarter earnings call that he saw future opportunities for HCA Healthcare Inc. to make “sizable acquisitions.” On Monday, the company made a Texas-sized buy. HCA has bought 24 MedSpring urgent care centers in Austin, Dallas and Houston from Fresenius Medical Care, according to a ne ws release. The facilities will be rebranded under HCA’s CareNow Urgent Care name.  Terms of the deal, which gives HCA 160 total urgent care centers across the country,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 5, 2019 Category: American Health Authors: Joel Stinnett Source Type: news

Pfizer completes acquisition of Therachon
Pfizer Inc. (NYSE: PFE) announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the terms of the transaction, Pfizer acquired Therachon for $340 million with an additional $470 million in additional payments contingent on the achievement of key milestones in the development and commercialization of TA-46. (Source: World Pharma News)
Source: World Pharma News - July 5, 2019 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Capital’s CCGs consolidate leadership pending mergers
There will be just two chief executives covering the 12 groups in south London from October, ahead of planned mergers in April next year. (Source: HSJ)
Source: HSJ - July 5, 2019 Category: UK Health Source Type: news

12 digital health mergers and acquisitions from Q2 2019, plus 5 IPOs
While most of the financials remain undisclosed, the quarter included a number of interesting deals involving Apple, Best Buy, UnitedHealth Group, and Allscripts. (Source: mobihealthnews)
Source: mobihealthnews - July 4, 2019 Category: Information Technology Source Type: news

Varian to buy 2 Boston Scientific product lines
Radiation therapy firm Varian Medical Systems has signed an agreement to acquire...Read more on AuntMinnie.comRelated Reading: Varian secures Tenn. Noona software contract Varian closes acquisition of cancer treatment provider Varian adds 2 interventional companies to roster Varian to acquire cancer treatment provider Varian completes ProBeam cyclotron install in Singapore (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 3, 2019 Category: Radiology Source Type: news

Centene increases stake in Spanish health care company
Clayton-based managed care company Centene announced Wednesday that it has expanded its stake in Spanish health care company Ribera Salud. The ownership stake was purchased from Spanish banking group Banco Sabadell. Centene now owns 90 percent of Ribera Salud, up from 50 percent, according to a release. Terms of the deal were not disclosed. Centene had invested $17 million in July 2014 to buy a noncontrolling interest in Ribera. Cen tene Chairman, President and CEO Michael Neidorff said the acquisition… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 3, 2019 Category: Biotechnology Authors: Vince Brennan Source Type: news

02.07.19: LEO Pharma completes the acquisition of Bayer's prescription dermatology business
LEO Pharma completes the acquisition of Bayer's prescription dermatology businessmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - July 2, 2019 Category: Pharmaceuticals Source Type: news

Mount Carmel parent Trinity Health names new CEO
Mount Carmel Health System's parent Trinity Health has promoted Mike Slubowski to CEO after two years as president and COO. The planned succession was first announced in December, when six-year CEO Dr. Richard Gilfillan announced he would resign at the end of June, citing the extended commute to Livonia, Michigan, from his home in Washington, D.C. The nonprofit Roman Catholic health system has 92 hospitals across 22 s tates, following the merger of Trinity and Catholic Health East five years ago.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 2, 2019 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

Mount Carmel parent Trinity Health names new CEO
Mount Carmel Health System's parent Trinity Health has promoted Mike Slubowski to CEO after two years as president and COO. The planned succession was first announced in December, when six-year CEO Dr. Richard Gilfillan announced he would resign at the end of June, citing the extended commute to Livonia, Michigan, from his home in Washington, D.C. The nonprofit Roman Catholic health system has 92 hospitals across 22 s tates, following the merger of Trinity and Catholic Health East five years ago.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 2, 2019 Category: Biotechnology Authors: Carrie Ghose Source Type: news

Boston Sci on the Other Side of M & amp;A in Its Deal with Varian
Varian Medical Systems is set to acquire Boston Scientific’s portfolio of drug-loadable microsphere and bland embolic bead products for $90 million. The deal is set to close in August. This is a stark departure Marlborough, MA-based Boston Scientific, who went on an acquisitions spree for most of 2018. However, the divestiture of these products is necessary, so it can satisfy anti-trust laws connected to its $4 billion acquisition of BTG. Varian's planned acquisition of the portfolio of drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products will enable ...
Source: MDDI - July 2, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
Company to acquire assets from Boston Scientific to expand embolic bead offering PALO ALTO, Calif., July 2, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it has signed an asset purchase agreement to acquire the Bo... Devices, Interventional, Acquisitions Varian Medical Systems, Boston Scientific, microsphere, embolic bead (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 2, 2019 Category: Pharmaceuticals Source Type: news

LEO Pharma completes the acquisition of Bayer ’s prescription dermatology business
LEO Pharma and Bayer announced today the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma. The companies first announced the proposed transaction on July 31, 2018 and completed the first step of the acquisition with the closing in the United States on September 4, 2018. (Source: World Pharma News)
Source: World Pharma News - July 2, 2019 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Carenet Health purchases Citra Health Solutions' telehealth, engagement subsidiary
While the terms of the transaction were not disclosed, this and a past acquisition signal Carenet's aims to turn  its virtual care services into a major market presence.  (Source: mobihealthnews)
Source: mobihealthnews - July 1, 2019 Category: Information Technology Source Type: news

Carenet Health acquisition to further expand its telehealth reach
San Antonio-based Carenet Health has agreed to buy Citra Health Solutions ’ telehealth subsidiary. The local company, already a significant player in telemedicine, expects to grow its business with the acquisition. While terms of the deal were not disclosed, it follows Carenet Health’s acquisition of HGS AxisPoint Health’s nurse advice line services. Carenet Healt h officials said this latest transaction extends and strengthens the company’s presence in the provider and health system market… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 1, 2019 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

Inconsistent condom use among female sex workers: partner-specific influences of substance use, violence, and condom coercion - Decker MR, Park JN, Allen ST, Silberzahn B, Footer K, Huettner S, Galai N, Sherman SG.
Female sex workers (FSWs) are disproportionately affected by HIV. Inconsistent condom use (ICU) represents the most proximal risk for acquisition and transmission. We evaluate associations of partner-specific factors including physical and sexual violence,... (Source: SafetyLit)
Source: SafetyLit - July 1, 2019 Category: International Medicine & Public Health Tags: Violence and Weapons Issues Source Type: news

Pfizer completes Therachon buy
Pfizer has announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company, Therachon Holding. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 1, 2019 Category: Pharmaceuticals Source Type: news

South Shore Health, Wellforce discuss potential merger
Four years after failing to merge with Partners HealthCare, South Shore Health is "in partnership discussions" with Burlington-based Wellforce, a possible precursor to a merger. The Weymouth-based health system which owns South Shore Hospital announced Monday that it had begun partnership discussions with the parent company for Tufts Medical Center, Hallmark Health and Lowell General Hospital. The health systems said they want to deliver health care in the community, cont rol health care costs,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 1, 2019 Category: Pharmaceuticals Authors: Jessica Bartlett Source Type: news

Novartis successfully completes acquisition of Xiidra ®, bolstering ophthalmic portfolio
Novartis today announced that it has completed its acquisition of Xiidra® (lifitegrast ophthalmic solution) 5%, the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease[1]. (Source: World Pharma News)
Source: World Pharma News - July 1, 2019 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Two execs step down as mega-merger trusts re-brand
Two members of the board overseeing the merger of three are stepping down from their leadership positions. (Source: HSJ)
Source: HSJ - July 1, 2019 Category: UK Health Source Type: news